Structural studies of Helicase NS3 variants from Hepatitis C virus genotype 3 in virological sustained responder and non-responder patients

BACKGROUND: About 130 million people are infected with the hepatitis C virus (HCV) worldwide, but effective treatment options are not yet available. One of the most promising targets for antiviral therapy is nonstructural protein 3 (NS3). To identify possible changes in the structure of NS3 associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Provazzi, Paola JS, Arcuri, Helen A, de Carvalho-Mello, Isabel Maria VG, Pinho, João Renato R, Nogueira, Maurício L, Palma, Mário S, Rahal, Paula
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919562/
https://www.ncbi.nlm.nih.gov/pubmed/20630078
http://dx.doi.org/10.1186/1756-0500-3-196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919562/
https://www.ncbi.nlm.nih.gov/pubmed/20630078
http://dx.doi.org/10.1186/1756-0500-3-196

Ejemplares similares